|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,636 GBX | -0.91% |
|
+1.58% | +12.81% |
| Apr. 24 | CureVac Begins Early Stage Portion of Investigational Vaccine Trial | MT |
| Apr. 24 | Global markets live: Heineken, AT&T Hasbro, Visa, Boeing... |  |
On February 2, 2023, the company announced an increase in its equity buyback plan by $1,000 million, thereby increasing the total authorization to $9,500 million.
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 1,636 GBX | -0.91% | +1.58% | 83.92B | ||
| 137.6 USD | +0.62% | +7.95% | 15.18B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +12.81% | 83.92B | |
| +25.61% | 672B | |
| +25.87% | 570B | |
| -5.24% | 360B | |
| +16.49% | 321B | |
| +8.28% | 300B | |
| +7.09% | 217B | |
| -9.12% | 204B | |
| +5.01% | 199B | |
| -8.75% | 149B |
GSK PLC 
